Cargando…
Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up
A 44‐year‐old woman who was quarantined for 5 days after the diagnosis of coronavirus disease of 2019 (COVID‐19) was transferred to our hospital with the complaint of chest pain. The patient was unvaccinated. Electrocardiography revealed ST elevation in the lateral leads. Echocardiographic biventric...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053182/ https://www.ncbi.nlm.nih.gov/pubmed/36401586 http://dx.doi.org/10.1002/ehf2.14228 |
_version_ | 1785015351445028864 |
---|---|
author | Usui, Eisuke Nagaoka, Eiki Ikeda, Hiroshi Ohmori, Mari Tao, Susumu Yonetsu, Taishi Maejima, Yasuhiro Arai, Hirokuni Amemiya, Kisaki Ikeda, Yoshihiko Sasano, Tetsuo |
author_facet | Usui, Eisuke Nagaoka, Eiki Ikeda, Hiroshi Ohmori, Mari Tao, Susumu Yonetsu, Taishi Maejima, Yasuhiro Arai, Hirokuni Amemiya, Kisaki Ikeda, Yoshihiko Sasano, Tetsuo |
author_sort | Usui, Eisuke |
collection | PubMed |
description | A 44‐year‐old woman who was quarantined for 5 days after the diagnosis of coronavirus disease of 2019 (COVID‐19) was transferred to our hospital with the complaint of chest pain. The patient was unvaccinated. Electrocardiography revealed ST elevation in the lateral leads. Echocardiographic biventricular dysfunction with oedematous wall thickening was identified. Cardiac enzyme levels were elevated; however, C‐reactive protein (CRP) levels, and the coronary angiogram were normal. The patient required mechanical circulatory support to stabilize haemodynamics and was treated with remdesivir, baricitinib, and intravenous methylprednisolone. She recovered after 13 days of mechanical support. Serial cardiac magnetic resonance imaging revealed acute myocardial oedema and subsequent fibrosis. An endomyocardial biopsy on admission showed mild interstitial inflammatory infiltrates with endomyocardial fibrous thickening and mild interstitial fibrosis of the myocardium. Normal CRP levels suggested minor involvement of interleukin (IL)‐6, supporting the efficacy of baricitinib. |
format | Online Article Text |
id | pubmed-10053182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100531822023-03-30 Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up Usui, Eisuke Nagaoka, Eiki Ikeda, Hiroshi Ohmori, Mari Tao, Susumu Yonetsu, Taishi Maejima, Yasuhiro Arai, Hirokuni Amemiya, Kisaki Ikeda, Yoshihiko Sasano, Tetsuo ESC Heart Fail Case Reports A 44‐year‐old woman who was quarantined for 5 days after the diagnosis of coronavirus disease of 2019 (COVID‐19) was transferred to our hospital with the complaint of chest pain. The patient was unvaccinated. Electrocardiography revealed ST elevation in the lateral leads. Echocardiographic biventricular dysfunction with oedematous wall thickening was identified. Cardiac enzyme levels were elevated; however, C‐reactive protein (CRP) levels, and the coronary angiogram were normal. The patient required mechanical circulatory support to stabilize haemodynamics and was treated with remdesivir, baricitinib, and intravenous methylprednisolone. She recovered after 13 days of mechanical support. Serial cardiac magnetic resonance imaging revealed acute myocardial oedema and subsequent fibrosis. An endomyocardial biopsy on admission showed mild interstitial inflammatory infiltrates with endomyocardial fibrous thickening and mild interstitial fibrosis of the myocardium. Normal CRP levels suggested minor involvement of interleukin (IL)‐6, supporting the efficacy of baricitinib. John Wiley and Sons Inc. 2022-11-19 /pmc/articles/PMC10053182/ /pubmed/36401586 http://dx.doi.org/10.1002/ehf2.14228 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Reports Usui, Eisuke Nagaoka, Eiki Ikeda, Hiroshi Ohmori, Mari Tao, Susumu Yonetsu, Taishi Maejima, Yasuhiro Arai, Hirokuni Amemiya, Kisaki Ikeda, Yoshihiko Sasano, Tetsuo Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up |
title | Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up |
title_full | Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up |
title_fullStr | Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up |
title_full_unstemmed | Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up |
title_short | Fulminant myocarditis with COVID‐19 infection having normal C‐reactive protein and serial magnetic resonance follow‐up |
title_sort | fulminant myocarditis with covid‐19 infection having normal c‐reactive protein and serial magnetic resonance follow‐up |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053182/ https://www.ncbi.nlm.nih.gov/pubmed/36401586 http://dx.doi.org/10.1002/ehf2.14228 |
work_keys_str_mv | AT usuieisuke fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT nagaokaeiki fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT ikedahiroshi fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT ohmorimari fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT taosusumu fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT yonetsutaishi fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT maejimayasuhiro fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT araihirokuni fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT amemiyakisaki fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT ikedayoshihiko fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup AT sasanotetsuo fulminantmyocarditiswithcovid19infectionhavingnormalcreactiveproteinandserialmagneticresonancefollowup |